Goal 3: Good Health and Well-Being
 |
McMaster researcher Gerry Wright is a trailblazer in antimicrobial discovery, leading the global fight against superbugs and antibiotic resistance. He leads a global network that is working to prevent future pandemics as part of SDG 3. |
Preventing A SLOW-MOVING CATASTROPHE
Antibiotics are essential to modern medicine. We rely on them to cure everything from pneumonia to meningitis. The infection control they provide makes life-saving treatments like cancer chemotherapy and heart transplants possible.
But widespread overuse of these drugs in agriculture and medicine have led bacteria to evolve, increasing resistance to penicillin and related medicines. Antibiotic resistance causes 700,000 deaths globally each year – a number that’s expected to rise to 10 million by 2050.
The stakes couldn’t be higher.
That’s why infectious disease expert Gerry Wright is working with teams of researchers to understand and detect antimicrobial resistance, and develop new treatments to stop this global threat in its tracks.
Featured Stories
Researchers identify novel immune cells that may worsen asthma
Researchers at McMaster University have identified a new population of immune cells that may play a crucial role in the severity of asthma symptoms. The . . .
McMaster researchers discover way to make drug-resistant bacteria vulnerable to common antibiotic
McMaster researchers have discovered a way to make deadly drug-resistant bacteria vulnerable to a commonly used antibiotic, opening the door to new utility for old . . .
Government of Canada invests $4M in McMaster to fast-track drug discovery initiatives
McMaster University has received $4 million in federal funding to upgrade and significantly expand its drug discovery infrastructure. With the new investment from the Federal . . .
Discover how Our Research is making an Impact
